Panhypopituitarism
Symptoms, Doctors, Treatments, Advances & More

Learn About Panhypopituitarism

What is the definition of Panhypopituitarism?

Combined pituitary hormone deficiency is a condition that causes a partial or complete loss (deficiency) of two or more hormones that are normally produced by the pituitary gland. The pituitary gland, which is located at the base of the brain, produces hormones that are needed for growth, development, and other critical body functions. A lack of pituitary hormones can affect growth and development.

What are the causes of Panhypopituitarism?

Variants (also called mutations) in several genes that play important roles in early development have been associated with congenital combined pituitary hormone deficiency. PROP1 gene variants are the most common genetic cause of congenital combined pituitary hormone deficiency and are more common in individuals with ancestors from Eastern Europe or the Iberian Peninsula. Variants in other genes have been identified in a smaller number of affected individuals.

How prevalent is Panhypopituitarism?

The congenital form of combined pituitary hormone deficiency occurs in approximately 1 in 16,000 individuals.

Is Panhypopituitarism an inherited disorder?

Congenital combined pituitary hormone deficiency can be inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Some cases of this condition are caused by new (de novo) variants in the gene that occur during the formation of reproductive cells (eggs or sperm) in an affected individual's parent or during early embryonic development. These affected individuals typically have no history of the disorder in their family.

Who are the top Panhypopituitarism Local Doctors?
Distinguished in Panhypopituitarism
Endocrinology
Distinguished in Panhypopituitarism
Endocrinology
Referral required

California Center For Pituitary Disorders

400 Parnassus Ave., Eighth Floor, 
San Francisco, CA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Lewis Blevins is an Endocrinologist practicing medicine in San Francisco, California. Dr. Blevins is rated as a Distinguished provider by MediFind in the treatment of Panhypopituitarism. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Hypothalamic Tumor, Prolactinoma, and Rathke Cleft Cyst. Dr. Blevins is board certified in American Board Of Internal Medicine, Endocrinology Diabetes & Metab. Dr. Blevins is currently accepting new patients.

Advanced in Panhypopituitarism
Internal Medicine
Advanced in Panhypopituitarism
Internal Medicine

Johnson City Internal Medicine

301 Med Tech Pkwy, Ste 240, 
Johnson City, TN 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Richard Rolen is a primary care provider, practicing in Internal Medicine in Johnson City, Tennessee. Dr. Rolen is rated as an Advanced provider by MediFind in the treatment of Panhypopituitarism. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Acute Coronary Syndrome, Kyphosis, Vitamin D Deficiency, and Growth Hormone Deficiency (GHD). Dr. Rolen is board certified in American Board Of Internal Medicine. Dr. Rolen is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Panhypopituitarism
Elite in Panhypopituitarism
Referral may be required
Avenida Dr. Eneas De C Aguiar, Andar Bloco, 
Sao Paulo, SP, BR 

Berenice Mendonca practices practicing medicine in Sao Paulo, Brazil. Ms. Mendonca is rated as an Elite expert by MediFind in the treatment of Panhypopituitarism. She is also highly rated in 57 other conditions, according to our data. Her clinical expertise encompasses Familial Hypopituitarism, Intersex, Precocious Puberty, Hormone Replacement Therapy (HRT), and Oophorectomy.

What are the latest Panhypopituitarism Clinical Trials?
A Clinical and Genetic Investigation of Pituitary and Hypothalamic Tumors and Related Disorders

Summary: There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central nervous system tumors in childhood. The gene(s) involved in the pathogenesis of these tumors are largely not known; their possible association with other developmental defects or inheritance pattern(s) has not been investigated. The present...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients With Acquired Hypothalamic Obesity

Summary: This is a sub-study of Study RM-493-040 (NCT05774756). The goal of this sub-study is to learn how well Setmelanotide works to improve weight reduction, hunger, and quality of life in patients 4 years of age and older with congenital Hypothalamic Obesity (cHO). To determine how well setmelanotide works and how safe it is, patients with cHO will take a daily injection of either setmelanotide or plac...

Who are the sources who wrote this article ?

Published Date: May 07, 2025
Published By: National Institutes of Health